digital currency online Featured snippets

China Merchants Securities: Investment Guidelines of the Central Economic Work Conference for A-shares next year From these four aspects, China Merchants Securities said that the investment guidelines of the Central Economic Work Conference for A-shares next year mainly include the following aspects: 1) From a macro perspective, the support intensity of policies for various economic work is expected to exceed market expectations. Specifically, the fiscal policy orientation is positive, deficit ratio will arrange or keep it above 3%, the issuance scale of ultra-long-term special government bonds will be further expanded, and the scale and investment field of special bonds are expected to be further extended; Monetary policy mentioned "timely lowering the RRR and cutting interest rates", and the goal of liquidity policy changed from balance to loose tendency, which will bring room for valuation improvement of A shares. 2) From the perspective of expanding domestic demand, consumption will become the main line of investment next year: the meeting will continue the deployment of the Politburo meeting in December, and in the order of writing, consumption will still be placed at the top of next year's key tasks. In terms of specific measures, it is planned to boost consumption mainly through two aspects. First, increase the income of residents; The second is to increase consumption scenarios. 3) Focus on scientific and technological innovation to lead the development of new quality productive forces, and grasp two main lines: this meeting focused on "carrying out' artificial intelligence+'action and cultivating future industries". Artificial intelligence has appeared in the draft of the Central Economic Work Conference for three consecutive years. Future industries have also appeared in the draft of the Central Economic Work Conference for two consecutive years. Therefore, it is recommended to focus on artificial intelligence+and future industries. 4) Focus on "comprehensive improvement of' involution' competition": In terms of "involution" competition, photovoltaic industry is the representative in emerging industries. Recently, in addition to self-regulatory measures such as industry association initiatives, the photovoltaic export tax rebate rate has been lowered and industry norms have been updated to further control new production capacity. The policy is further introduced to curb the "involution" competition of photovoltaics. It is recommended to pay attention to photovoltaic, lithium battery and other industries.Zuo Qiang served as the chairman and secretary of the Party Committee of China Construction No.1 Bureau (Group) Co., Ltd. On the afternoon of December 13th, China Construction No.1 Bureau (Group) Co., Ltd. held a meeting of cadres and workers. China Construction Group announced the decision to supplement the main leaders of China Construction No.1 Bureau (Group) Co., Ltd.: Comrade Zuo Qiang is the chairman and party secretary of China Construction No.1 Bureau (Group) Co., Ltd.From January to October, the national output of photovoltaic polysilicon, silicon wafers, batteries and components all increased by more than 20% year-on-year. According to the Ministry of Industry and Information Technology, from January to October 2024, China's photovoltaic industry operated smoothly as a whole. According to the announcement of photovoltaic industry norms, enterprise information and industry associations, the output of photovoltaic polysilicon, silicon wafers, batteries and components in China increased by more than 20% year-on-year, and the export volume of photovoltaic cells increased by more than 40%. In the polysilicon sector, the national output from January to October was about 1.58 million tons, up 39.0% year-on-year. In the silicon wafer link, the national output from January to October was about 608GW, and the export volume was about 53.2GW. In the battery sector, from January to October, the national output of crystalline silicon batteries was about 510GW, and the export volume was about 45.9GW. In terms of components, from January to October, the national output of crystalline silicon components was about 453GW, and the export volume was about 205.9GW.

Yiwei lithium can pass the medical device quality management system certification (ISO 13485:2016). Yiwei lithium news, recently, Yiwei lithium can obtain the medical device quality management system certification (ISO 13485:2016) issued by DNV, and the certification scope includes the design, manufacture and sales of lithium batteries and secondary lithium batteries for medical devices. It indicates that Yiwei lithium can reach the international level in research and development, manufacturing and quality management of medical battery products.The annual evaluation report of the big model in the financial field was released, and the big model of Step Star/Fortune Leap Star performed well. The 6th Shanghai International Forum on Financial Technology was held in Shanghai. At the meeting, Shanghai Artificial Intelligence Laboratory, together with Shanghai University of Finance and Economics and Shanghai Cooper Technology Co., Ltd., released the Report on Evaluation of Large Models in Financial Field (2024), which comprehensively evaluated 20 models from five dimensions: model basic ability, financial security and value alignment ability, financial risk control ability, financial professional cognitive ability and financial business auxiliary expansion ability. The comprehensive scores of Anthropic, Step Star/Fortune Star and Alibaba ranked in the top three. Step-2-16k model of Step Star/Fortune Star got the second comprehensive score, and the multi-modal comprehensive score of Finstep model got the first.He ertai bought 199 million yuan and sold 155 million yuan in Shenzhen Stock Connect today. He ertai bought 199 million yuan and sold 155 million yuan today, with a turnover of 6.304 billion yuan and a turnover rate of 3.727%. After-hours data showed that the special seats of Shenzhen Stock Connect bought 199 million yuan and sold 155 million yuan.

Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Market News: The Bank of Japan will consider not raising interest rates at its next policy meeting.ST Mo Long and other materials companies have set up sales business of renewable resources. The enterprise search APP shows that recently, Shandong Cangyuan Materials Co., Ltd. was established, with Liu Shuai as the legal representative and a registered capital of 5 million yuan. Its business scope includes: sales of machinery and equipment; Sales of coal and products; Sales of renewable resources; Import and export agents, etc. Enterprise equity penetration shows that the company is jointly held by ST Mo Long and others.